Thyrotoxic periodic paralysis
A case of thyrotoxic periodic paralysis is reported in a Hispanic man with an unusual recurrence six weeks after radioactive iodine treatment. Thyrotoxic periodic paralysis has now been well characterized in the literature: it occurs primarily in Orientals with an overwhelming male preponderance and a higher association of specific HLA antigens. Clinical manifestations include onset after high carbohydrate ingestion or heavy exertion, with progressive symmetric weakness leading to flaccid paralysis of the extremities and other muscle groups, lasting several hours. If hypokalemia is present, potassium administration may help abort the attack. Although propranolol can be efficacious in preventing further episodes, the only definitive treatment is establishing a euthyroid state. The pathophysiology is still controversial, but reflects altered potassium and calcium dynamics as well as certain morphologic characteristics within the muscle unit itself.
- Research Organization:
- Univ. of Miami School of Medicine, FL
- OSTI ID:
- 5942034
- Journal Information:
- Am. J. Med.; (United States), Vol. 1
- Country of Publication:
- United States
- Language:
- English
Similar Records
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis
Model of iodine metabolism in a T3-thyrotoxic patient undergoing I-131 therapy
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
RADIOTHERAPY
SIDE EFFECTS
THYROID
BIOLOGICAL RADIATION EFFECTS
CALCIUM
CARCINOMAS
HISPANIC AMERICANS
HYPERTHYROIDISM
PATHOGENESIS
PATIENTS
POTASSIUM
ALKALI METALS
ALKALINE EARTH METALS
BIOLOGICAL EFFECTS
BODY
DISEASES
ELEMENTS
ENDOCRINE DISEASES
ENDOCRINE GLANDS
GLANDS
HUMAN POPULATIONS
MEDICINE
METALS
MINORITY GROUPS
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
POPULATIONS
RADIATION EFFECTS
RADIOLOGY
THERAPY
560161* - Radionuclide Effects
Kinetics
& Toxicology- Man
550604 - Medicine- Unsealed Radionuclides in Therapy- (1980-)